The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ACLARIS THERAPEUTICS INC | COM | 00461U105 | 15,120 | 600,000 | SH | SOLE | 600,000 | 0 | 0 | ||
| ALDEYRA THERAPEUTICS INC | COM | 01438T106 | 7,722 | 650,000 | SH | SOLE | 650,000 | 0 | 0 | ||
| AMICUS THERAPEUTICS INC | COM | 03152W109 | 2,618 | 265,000 | SH | SOLE | 265,000 | 0 | 0 | ||
| APELLIS PHARMACEUTICALS INC | COM | 03753U106 | 9,655 | 225,000 | SH | SOLE | 225,000 | 0 | 0 | ||
| APTEVO THERAPEUTICS INC | COM NEW | 03835L207 | 1,526 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
| ARK ETF TR | GENOMIC REV ETF | 00214Q302 | 17,746 | 200,000 | SH | Put | SOLE | 200,000 | 0 | 0 | |
| ARVINAS INC | COM | 04335A105 | 13,551 | 205,000 | SH | SOLE | 205,000 | 0 | 0 | ||
| ASCENDIS PHARMA A/S | SPONSORED ADR | 04351P101 | 17,399 | 135,000 | SH | SOLE | 135,000 | 0 | 0 | ||
| BICYCLE THERAPEUTICS PLC | SPONSORED ADS | 088786108 | 4,481 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | ||
| BIOCRYST PHARMACEUTICALS INC | COM | 09058V103 | 5,085 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | ||
| BIOGEN INC | COM | 09062X103 | 5,595 | 20,000 | SH | SOLE | 20,000 | 0 | 0 | ||
| CASI PHARMACEUTICALS INC | COM | 14757U109 | 1,560 | 650,000 | SH | SOLE | 650,000 | 0 | 0 | ||
| CATALYST BIOSCIENCES INC | COM NEW | 14888D208 | 5,040 | 1,000,000 | SH | SOLE | 1,000,000 | 0 | 0 | ||
| CELLDEX THERAPEUTICS INC NEW | COM NEW | 15117B202 | 2,060 | 100,000 | SH | Put | SOLE | 100,000 | 0 | 0 | |
| CELLDEX THERAPEUTICS INC NEW | COM NEW | 15117B202 | 5,150 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | ||
| CHIMERIX INC | COM | 16934W106 | 1,928 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
| COGENT BIOSCIENCES INC | COM | 19240Q201 | 14,048 | 1,600,000 | SH | SOLE | 1,600,000 | 0 | 0 | ||
| CONSTELLATION PHARMCETICLS I | COM | 210373106 | 6,432 | 275,000 | SH | SOLE | 275,000 | 0 | 0 | ||
| CTI BIOPHARMA CORP | COM | 12648L601 | 2,183 | 750,000 | SH | SOLE | 750,000 | 0 | 0 | ||
| CURIS INC | COM NEW | 231269200 | 4,811 | 425,000 | SH | SOLE | 425,000 | 0 | 0 | ||
| ESSA PHARMA INC | COM NEW | 29668H708 | 5,084 | 175,000 | SH | SOLE | 175,000 | 0 | 0 | ||
| FATE THERAPEUTICS INC | COM | 31189P102 | 15,253 | 185,000 | SH | SOLE | 185,000 | 0 | 0 | ||
| FIBROGEN INC | COM | 31572Q808 | 4,339 | 125,000 | SH | SOLE | 125,000 | 0 | 0 | ||
| FREQUENCY THERAPEUTICS INC | COM | 35803L108 | 950 | 100,000 | SH | Put | SOLE | 100,000 | 0 | 0 | |
| HELIX ACQUISITION CORP | COM CL A | G4444C102 | 5,118 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | ||
| IMMUNIC INC | COM | 4525EP101 | 4,224 | 265,000 | SH | SOLE | 265,000 | 0 | 0 | ||
| IMMUNOVANT INC | COM | 45258J102 | 4,010 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | ||
| INVESCO QQQ TR | UNIT SER 1 | 46090E103 | 47,870 | 150,000 | SH | Put | SOLE | 150,000 | 0 | 0 | |
| IOVANCE BIOTHERAPEUTICS INC | COM | 462260100 | 15,830 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | ||
| ISHARES TR | RUSSELL 2000 ETF | 464287655 | 6,628 | 30,000 | SH | SOLE | 30,000 | 0 | 0 | ||
| IVERIC BIO INC | COM | 46583P102 | 6,953 | 1,125,000 | SH | SOLE | 1,125,000 | 0 | 0 | ||
| KADMON HLDGS INC | COM | 48283N106 | 2,334 | 600,000 | SH | SOLE | 600,000 | 0 | 0 | ||
| KURA ONCOLOGY INC | COM | 50127T109 | 16,962 | 600,000 | SH | SOLE | 600,000 | 0 | 0 | ||
| MERSANA THERAPEUTICS INC | COM | 59045L106 | 7,281 | 450,000 | SH | SOLE | 450,000 | 0 | 0 | ||
| MIRATI THERAPEUTICS INC | COM | 60468T105 | 8,565 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
| NOVAVAX INC | COM NEW | 670002401 | 3,173 | 17,500 | SH | SOLE | 17,500 | 0 | 0 | ||
| NUVATION BIO INC | COM CL A | 67080N101 | 4,964 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | ||
| OTONOMY INC | COM | 68906L105 | 1,148 | 450,000 | SH | SOLE | 450,000 | 0 | 0 | ||
| PRECISION BIOSCIENCES INC | COM | 74019P108 | 2,070 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
| ROCKET PHARMACEUTICALS INC | COM | 77313F106 | 14,420 | 325,000 | SH | SOLE | 325,000 | 0 | 0 | ||
| SAGE THERAPEUTICS INC | COM | 78667J108 | 2,246 | 30,000 | SH | SOLE | 30,000 | 0 | 0 | ||
| SATSUMA PHARMACEUTICALS INC | COM | 80405P107 | 5,136 | 904,225 | SH | SOLE | 904,225 | 0 | 0 | ||
| SIERRA ONCOLOGY INC | COM NEW | 82640U404 | 3,446 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
| SYNDAX PHARMACEUTICALS INC | COM | 87164F105 | 26,273 | 1,175,000 | SH | SOLE | 1,175,000 | 0 | 0 | ||
| TG THERAPEUTICS INC | COM | 88322Q108 | 9,640 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
| TRILLIUM THERAPEUTICS INC | COM NEW | 89620X506 | 20,943 | 1,950,000 | SH | SOLE | 1,950,000 | 0 | 0 | ||
| VERONA PHARMA PLC | SPONSORED ADS | 925050106 | 7,850 | 939,043 | SH | SOLE | 939,043 | 0 | 0 | ||
| VIRIDIAN THERAPEUTICS INC | COM | 92790C104 | 5,013 | 300,000 | SH | SOLE | 300,000 | 0 | 0 | ||
| VISTAGEN THERAPEUTICS INC | COM NEW | 92840H202 | 8,826 | 4,143,702 | SH | SOLE | 4,143,702 | 0 | 0 | ||
| XENON PHARMACEUTICALS INC | COM | 98420N105 | 15,215 | 850,000 | SH | SOLE | 850,000 | 0 | 0 | ||